Opiant Pharmaceuticals to present at Jefferies Virtual London Healthcare Conference
Opiant Pharmaceuticals, Inc. (Nasdaq: OPNT) will participate in the 12th Jefferies London Healthcare Conference virtually on November 18-19, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Opiant Pharmaceuticals, Inc. (Nasdaq: OPNT) will participate in the 12th Jefferies London Healthcare Conference virtually on November 18-19, 2021. Senior management will engage in investor one-on-one meetings during the event. A webcast of the conference will be available on the company's website starting November 18 at 8:00 AM GMT / 3:00 AM ET. Opiant is known for developing NARCAN® Nasal Spray and is focused on creating innovative treatments for addiction and drug overdose.
Details
News Market Reaction – OPNT
The recorded move for OPNT in the trading session of this news was +1.21%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA MONICA, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT), a company advancing medicines to better treat addictions and drug overdose, today announced that members of the company’s senior management team will participate in the 12th Jefferies London Healthcare Conference virtually on Thursday, November 18 and Friday, November 19. Management will participate in investor 1x1 meetings on both days. A webcast of the event will be available from November 18, 2021, 8:00 AM GMT / 3:00 AM ET on the Opiant website.
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.
For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.